Dr. Jesús Fernández-Lucas has been an Associate Professor at Complutense University of Madrid since 2023. He earned his European Ph.D. in Pharmacy from the same institution in 2008, graduating summa cum laude and receiving the UCM Ph.D. Award. From 2011 to 2023, Dr. Fernández-Lucas was part of the Department of Pharmacy and Biotechnology at the European University of Madrid, where he founded the Applied Biotechnology Group (ABG-UEM) in 2013. This research group, currently comprising three senior researchers, three Ph.D. students, and two other students, continues under his supervision. Additionally, Dr. Fernández-Lucas is a visiting professor at Universidad de la Costa in Barranquilla, Colombia, and a co-founder of CALDOCK SAS, a university spin-off in Colombia. His research interests span biochemistry, organic chemistry, bioprocesses, extremophiles, nanotechnology, bioinformatics, biomedicine, and psychophysiology, with a primary focus on the biotechnological and biomedical applications of enzymes from the purine and pyrimidine salvage pathways.
Dr. Jesús Fernández-Lucas has been an Associate Professor at Complutense University of Madrid since 2023. He earned his European Ph.D. in Pharmacy from the same institution in 2008, graduating summa cum laude and receiving the UCM Ph.D. Award. From 2011 to 2023, Dr. Fernández-Lucas was part of the Department of Pharmacy and Biotechnology at the European University of Madrid, where he founded the Applied Biotechnology Group (ABG-UEM) in 2013. This research group, currently comprising three senior researchers, three Ph.D. students, and two other students, continues under his supervision. Additionally, Dr. Fernández-Lucas is a visiting professor at Universidad de la Costa in Barranquilla, Colombia, and a co-founder of CALDOCK SAS, a university spin-off in Colombia. His research interests span biochemistry, organic chemistry, bioprocesses, extremophiles, nanotechnology, bioinformatics, biomedicine, and psychophysiology, with a primary focus on the biotechnological and biomedical applications of enzymes from the purine and pyrimidine salvage pathways.